Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,030.00
+20.00 (0.50%)
At close: Jun 5, 2025, 3:30 PM KST
-29.79%
Market Cap 275.87B
Revenue (ttm) 173.50B
Net Income (ttm) -798.97M
Shares Out 68.45M
EPS (ttm) -12.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 45,990
Average Volume 103,251
Open 4,025.00
Previous Close 4,010.00
Day's Range 4,015.00 - 4,055.00
52-Week Range 3,500.00 - 6,090.00
Beta 0.84
RSI 61.86
Earnings Date May 13, 2025

About Bukwang Pharmaceutical

Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication... [Read more]

Sector Healthcare
Founded 1960
Employees 606
Stock Exchange Korea Stock Exchange
Ticker Symbol 003000
Full Company Profile

Financial Performance

In 2024, Bukwang Pharmaceutical's revenue was 160.09 billion, an increase of 27.13% compared to the previous year's 125.93 billion. Losses were -2.64 billion, -91.57% less than in 2023.

Financial Statements

News

There is no news available yet.